PV701
AXP000115.1 · Oncolytic virus
- Platform
- Newcastle disease virus (attenuated MK107 lineage)
- Originator
- Pro-Virus
- Sponsor
- Wellstat Biologics
Names
| Name | Type | Source |
|---|---|---|
| PV701 | preferred name, code | curator, ncit |
| Oncolytic Newcastle Disease Virus Strain PV701 | synonym | ncit |
Virus
- Role
- Oncolytic
- Family
- Paramyxoviridae
- Virus
- Newcastle disease virus (NCBI Taxonomy 2560319)
- Strain
- PV701 (attenuated MK107 lineage)
- Replication
- replicating
- Modifications
- none (naturally attenuated, non-recombinant)
- Route
- intravenous
- Source
- evidence
Cross-references
- NCI Thesaurus
- C2799
Approvals
No regulatory approval recorded.
Clinical trials (2)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT00081211 | Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck | Terminated | Phase 1 | 2004-04 | 2004-07 | 30 | Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Salivary Gland Squamous Cell Carcinoma; Stage III Salivary Gland Cancer; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squamous Cell Carcinoma of the Nasopharynx; Stage III Squamous Cell Carcinoma of the Oropharynx; Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity |
| NCT00055705 | PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer | Completed | Phase 1 | 2003-01 | Cancer |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 17289893 | An optimized clinical regimen for the oncolytic virus PV701. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2007 | name in title: PV701 |
| PMID 16638865 | A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2006 | name in title: PV701 |
| PMID 11980996 | Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2002 | name in title: PV701 |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 17346102 | Oncolytic virus therapy--foreword. | Current cancer drug targets | 2007 | name in abstract: PV701 |
| PMID 17346107 | Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus. | Current cancer drug targets | 2007 | name in title: PV701 |
| PMID 15983551 | A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy. | Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2005 | name in title: PV701 |
| PMID 14571286 | Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology | 2003 | name in abstract: PV701 |
| PMID 14755888 | Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. | Current opinion in molecular therapeutics | 2003 | name in title: PV701 |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| M01RR000040 | UPCC: TRIAL OF INTRAVENOUS PV701 IN PTS W SOLID TUMORS | UNIVERSITY OF PENNSYLVANIA | STERMAN, DANIEL | 1999–2002 | name in title: PV701 |
Notes
Naturally attenuated, non-recombinant mesogenic NDV. Developed by Pro-Virus, which became Wellstat Biologics. Discontinued; no active trials found.
How to cite
PV701 (AXP000115.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000115.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.